|
Disclaimer: FOR TEST AND EXAMPLE PURPOSES ONLY! These web pages are not intended to be used as a source of information on medicines.
The web pages are not kept up to date and are for demonstration purposes only.
For up-to-date information on a medicine, please consult www.ema.europa.eu/medicines or the package leaflet of your medicine.
|
BACK TO LIST |
European Patient Summary
|
|
|
|||||||||||||||||||
Problem list
| Condition | Onset Date | Status |
|---|---|---|
| Essential hypertension | 26-Nov-2020 | active |
Medication list
| Medication | Since | Form | Dosage | Reason |
|---|---|---|---|---|
| Lisinopril 10 mg oral tablet | 2024-12-26 | - | 1 tablet (10 mg) by mouth once daily | Essential hypertension (disorder) |
Immunizations list
| Vaccine | Date |
|---|---|
| Influenza virus antigen only vaccine product | 26-Dec-2024 |
| Clostridium tetani toxoid antigen adsorbed only vaccine product | 09-Dec-2021 |
| SARS-CoV-2 mRNA vaccine | 11-Nov-2021 |
Procedure History list
| Procedure | Date | Reason |
|---|---|---|
| Depression screening | 26-Nov-2020 | - |
| Assessment of health and social care needs | 26-Nov-2020 | - |
| Assessment of anxiety | 26-Nov-2020 | - |
| Screening for drug abuse | 26-Nov-2020 | - |
| Screening for domestic abuse | 26-Nov-2020 | - |
| Assessment of substance use | 26-Nov-2020 | - |
| Depression screening using Patient Health Questionnaire Two-Item score (procedure) | 26-Nov-2020 | - |
Allergies and Intolerances
| Allergy/Intolerance | Onset Date | Status | Type | Reaction |
|---|---|---|---|---|
| ? | active | ? |
Care Plan
| Active Planned Care / Goals | Start Date | Reason |
|---|---|---|
| Lifestyle education regarding hypertension | 26-Nov-2020 | Essential hypertension (disorder) |
|
Vital Signs
| Vital Signs | 2024-12-26 | 2023-12-21 |
|---|---|---|
| Body Height | 185.6 cm | 185.6 cm |
| Pain severity - 0-10 verbal numeric rating [Score] - Reported | 0 {score} | 1 {score} |
| Body Weight | 90.5 kg | 88.7 kg |
| Body mass index (BMI) [Ratio] | 26.3 kg/m2 | 25.8 kg/m2 |
| Diastolic Blood Pressure | 109 mm[Hg] | 111 mm[Hg] |
| Systolic Blood Pressure | 136 mm[Hg] | 140 mm[Hg] |
| Heart rate | 91 /min | 83 /min |
| Respiratory rate | 14 /min | 13 /min |
Relevant diagnostic tests/laboratory data
| Recent Lab Observations | 21-DEC-2023 | Reference Range | Unit |
|---|---|---|---|
| Cholesterol [Mass/volume] in Serum or Plasma | 175.4 | 125 - 200 | mg/dL |
| Triglyceride [Mass/volume] in Serum or Plasma | 100.3 | 40 - 150 | mg/dL |
| Cholesterol in LDL [Mass/volume] in Serum or Plasma by Direct assay | 103.0 | 0 - 130 | mg/dL |
| Cholesterol in HDL [Mass/volume] in Serum or Plasma | 52.4 | 40 - 60 | mg/dL |
| Leukocytes [#/volume] in Blood by Automated count | 5.3 | 3.5 - 10.5 | 10*3/uL |
| Erythrocytes [#/volume] in Blood by Automated count | 4.6 | 4.5 - 5.5 | 10*6/uL |
| Hemoglobin [Mass/volume] in Blood | 14.1 | 14 - 18 | g/dL |
| Hematocrit [Volume Fraction] of Blood by Automated count | 37.1 L | 38 - 50 | % |
| MCV [Entitic volume] by Automated count | 82.0 | 80 - 98 | fL |
| MCH [Entitic mass] by Automated count | 28.4 | 27 - 34 | pg |
| MCHC [Mass/volume] by Automated count | 34.0 | 32 - 36 | g/dL |
| Erythrocyte distribution width [Entitic volume] by Automated count | 39.7 | 39 - 55 | fL |
| Platelets [#/volume] in Blood by Automated count | 231.5 | 150 - 400 | 10*3/uL |
| Platelet distribution width [Entitic volume] in Blood by Automated count | 236.3 H | 13.4 - 17.4 | fL |
| Platelet mean volume [Entitic volume] in Blood by Automated count | 12.3 | 7.2 - 13.8 | fL |